Showing all 1 result

  • Sale! Buy portrazza necitumumab vial

    Portrazza (necitumumab)

    $820.00 $750.00

    Portrazza (necitumumab) is a medication used for the treatment of metastatic squamous non-small cell lung cancer.

    Oncology Lung Cancer
    Marketing Authorisation Holder Eli Lilly Nederland B.V.
    Mode of Action Epidermal Growth Factor (EGFR) Antagonist (immunotherapy)
    Administration Intravenous
    Regulatory agency approval European Medical Agency (EMA), European Union, Food and Drug Administration (FDA), USA
    Strength 800 / 50 milligram / millilitre
    Package 1 Vials